{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:02:20Z","timestamp":1779760940607,"version":"3.53.1"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114863","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:14:12Z","timestamp":1774545252000},"page":"114863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Toward animal-free approaches in subcutaneous drug delivery: A pain management case study"],"prefix":"10.1016","volume":"394","author":[{"given":"Remo","family":"Eugster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklaas","family":"Manten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Buttitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz","family":"Chwatal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sch\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bergadano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Aleandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114863_bb0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s44222-024-00161-w","article-title":"Subcutaneous drug delivery from nanoscale systems","volume":"2","author":"Lorenzo","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.jconrel.2026.114863_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106181","article-title":"Overview of authorized drug products for subcutaneous administration: pharmaceutical, therapeutic, and physicochemical properties","volume":"173","author":"Dubbelboer","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0015","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1124\/dmd.114.059121","article-title":"Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins","volume":"42","author":"Kagan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2026.114863_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.03.011","article-title":"Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site","volume":"182","author":"Kinnunen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114863_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106226","article-title":"Revolutionizing animal health: A comprehensive review of long-acting formulations","volume":"101","author":"Manasa","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0030","doi-asserted-by":"crossref","first-page":"114739","DOI":"10.1016\/j.jconrel.2026.114739","article-title":"Physiologically controlled release from an in situ forming liposomal depot","volume":"392","author":"Eugster","year":"2026","journal-title":"J. Control Release"},{"key":"10.1016\/j.jconrel.2026.114863_bb0035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","article-title":"Clinical translation of long-acting drug delivery formulations","volume":"7","author":"Li","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114863_bb0040","doi-asserted-by":"crossref","first-page":"17295","DOI":"10.1038\/s41598-020-74230-6","article-title":"Design and in vivo evaluation of a microparticulate depot formulation of buprenorphine for veterinary use","volume":"10","author":"Schreiner","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114863_bb0045","unstructured":"T. McDonald, M. L Zepeda, M. Tomlinson, W. Bee, I. Ivens, Subcutaneous administration of biotherapeutics: Current experience in animal models, Curr. Opin. Mol. Ther. 12 (927) 461\u2013470."},{"key":"10.1016\/j.jconrel.2026.114863_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106412","article-title":"Development of a bio-relevant in vitro release testing method for subcutaneous and intramuscular oil depot formulations","volume":"102","author":"\u00d8stergaard","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0963180115000079","article-title":"The flaws and human harms of animal experimentation","volume":"24","author":"Akhtar","year":"2015","journal-title":"Camb. Q. Healthc. Ethics"},{"key":"10.1016\/j.jconrel.2026.114863_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41684-023-01308-9","article-title":"Challenging current scientific practice: how a shift in research methodology could reduce animal use","volume":"53","author":"Richter","year":"2024","journal-title":"Lab. Anim."},{"key":"10.1016\/j.jconrel.2026.114863_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s42826-024-00198-3","article-title":"3R-refinement principles: elevating rodent well-being and research quality","volume":"40","author":"Rinwa","year":"2024","journal-title":"Lab Anim Res"},{"key":"10.1016\/j.jconrel.2026.114863_bb0070","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1038\/s41598-023-30641-9","article-title":"A buprenorphine depot formulation provides effective sustained post-surgical analgesia for 72 h in mouse femoral fracture models","volume":"13","author":"Wolter","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114863_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12060567","article-title":"Injectable lipid-based depot formulations: where do we stand?","volume":"12","author":"Rahnfeld","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114863_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105904","article-title":"A call to action: advancing new approach methodologies (NAMs) in regulatory toxicology through a unified framework for validation and acceptance","volume":"162","author":"Ouedraogo","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41587-025-02690-0","article-title":"FDA pushes to replace animal testing","volume":"43","author":"Harrison","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpb.2022.11.019","article-title":"Development and in vivo validation of phospholipid-based depots for the sustained release of bupivacaine","volume":"181","author":"Aleandri","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s43588-024-00620-9","article-title":"SimuCell3D: three-dimensional simulation of tissue mechanics with cell polarization","volume":"4","author":"Runser","year":"2024","journal-title":"Nat Comput Sci"},{"key":"10.1016\/j.jconrel.2026.114863_bb0100","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.xphs.2022.04.005","article-title":"Evaluation of in vitro tools to predict the in vivo absorption of biopharmaceuticals following subcutaneous administration","volume":"111","author":"Bender","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124227","article-title":"Prediction of subcutaneous drug absorption \u2212 development of novel simulated interstitial fluid media for predictive subcutaneous in vitro assays","volume":"658","author":"Torres-Ter\u00e1n","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ipha.2024.11.002","article-title":"Enhancing drug discovery with AI: predictive modeling of pharmacokinetics using graph neural networks and ensemble learning","volume":"3","author":"Satheeskumar","year":"2025","journal-title":"Intelligent Pharmacy"},{"key":"10.1016\/j.jconrel.2026.114863_bb0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cpt.3165","article-title":"Machine learning and artificial intelligence in PK-PD Modeling: fad, friend, or foe?","volume":"115","author":"Huang","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.114863_bb0120","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1021\/acs.molpharmaceut.2c00027","article-title":"Prediction of in vivo pharmacokinetic parameters and time-exposure curves in rats using machine learning from the chemical structure","volume":"19","author":"Obrezanova","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0125","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1021\/acs.jmedchem.5c00340","article-title":"Application of machine learning and mechanistic Modeling to predict intravenous pharmacokinetic profiles in humans","volume":"68","author":"Jia","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114863_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102546","article-title":"Artificial intelligence for compound pharmacokinetics prediction","volume":"79","author":"Obrezanova","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125490","article-title":"Development of an ex vivo human skin model and evaluation of biological responses to subcutaneously injected hyaluronic acid formulations","volume":"674","author":"Gou","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.05.005","article-title":"An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers","volume":"175","author":"Xu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114863_bb0145","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159762","article-title":"Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes","volume":"7","author":"Merleev","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.114863_bb0150","doi-asserted-by":"crossref","first-page":"24054","DOI":"10.1038\/s41598-024-75291-7","article-title":"A human ex vivo skin model breaking boundaries","volume":"14","author":"Wurbs","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114863_bb0155","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1208\/s12248-011-9303-8","article-title":"Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems","volume":"13","author":"Martinez","year":"2011","journal-title":"AAPS Journal"},{"key":"10.1016\/j.jconrel.2026.114863_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20417314211028574","article-title":"3D bioprinting for skin tissue engineering: current status and perspectives","volume":"12","author":"Weng","year":"2021","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.jconrel.2026.114863_bb0165","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1039\/D1MH00508A","article-title":"3D printing of artificial skin patches with bioactive and optically active polymer materials for anti-infection and augmenting wound repair","volume":"9","author":"Zhao","year":"2022","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.jconrel.2026.114863_bb0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s43246-025-00839-7","article-title":"3D printing of self-healing longevous multi-sensory e-skin","volume":"6","author":"Georgopoulou","year":"2025","journal-title":"Commun. Mater."},{"key":"10.1016\/j.jconrel.2026.114863_bb0175","first-page":"1567","article-title":"3D printing injectable microbeads using a composite liposomal ink for local treatment of peritoneal diseases, drug Deliv","volume":"14","author":"Eugster","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2026.114863_bb0180","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad3a14","article-title":"3D printing processes in precise drug delivery for personalized medicine","volume":"16","author":"Peng","year":"2024","journal-title":"Biofabrication"},{"key":"10.1016\/j.jconrel.2026.114863_bb0185","article-title":"Applications of 3D printing in medicine: A review, Ann 3D","volume":"14","author":"Dong","year":"2024","journal-title":"Print Med"},{"key":"10.1016\/j.jconrel.2026.114863_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202301930","article-title":"3D-printed lipid mesophases for the treatment of chronic liver disease","volume":"9","author":"Carone","year":"2024","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125761","article-title":"3D-printed cannabidiol stent for local treatment of urinary tract infections","volume":"680","author":"Eugster","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0200","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jconrel.2023.07.017","article-title":"Biofunctionalization of 3D printed collagen with bevacizumab-loaded microparticles targeting pathological angiogenesis","volume":"360","author":"Abbadessa","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114863_bb0205","first-page":"178","article-title":"Tailoring bioinks of extrusion-based bioprinting for cutaneous wound healing","volume":"17","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114863_bb0210","article-title":"Fabrication of 3D printing scaffold with porcine skin decellularized bio-ink for soft tissue engineering","volume":"13","author":"Lee","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.jconrel.2026.114863_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103583","article-title":"Protocol for the fabrication of self-standing (nano)cellulose-based 3D scaffolds for tissue engineering","volume":"6","author":"Mohan","year":"2025","journal-title":"STAR Protoc"},{"key":"10.1016\/j.jconrel.2026.114863_bb0220","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.3390\/ma13163522","article-title":"Fabrication of 3D printing scaffold with porcine skin decellularized bio-ink for soft tissue engineering","volume":"13","author":"Lee","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.jconrel.2026.114863_bb0225","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1016\/j.biomaterials.2012.06.051","article-title":"A hydrogel derived from decellularized dermal extracellular matrix","volume":"33","author":"Wolf","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114863_bb0230","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/03639045.2017.1291672","article-title":"Design of experiments (DoE) in pharmaceutical development","volume":"43","author":"Politis","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124460","article-title":"Scalable microfluidic method for tunable liposomal production by a design of experiment approach","volume":"662","author":"Buttitta","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202000098","article-title":"Beyond trial and error: A systematic development of liposomes targeting primary macrophages","volume":"1","author":"Weber","year":"2021","journal-title":"Adv. Nanobiomed Res."},{"key":"10.1016\/j.jconrel.2026.114863_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.112651","article-title":"Alginate, hyaluronic acid, and chitosan-based 3D printing hydrogel for cartilage tissue regeneration","volume":"202","author":"Jo Jang","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114863_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2023.109178","article-title":"3D printing windows and rheological properties for normal maize starch\/sodium alginate composite gels","volume":"146","author":"Cui","year":"2024","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2026.114863_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/md21030189","article-title":"Alginate-based biomaterials in tissue engineering and regenerative medicine","volume":"21","author":"Farshidfar","year":"2023","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jconrel.2026.114863_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fmats.2020.00086","article-title":"Printability of a cellulose derivative for extrusion-based 3D printing: the application on a biodegradable support material","volume":"7","author":"Cheng","year":"2020","journal-title":"Front. Mater."},{"key":"10.1016\/j.jconrel.2026.114863_bb0265","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.promfg.2019.06.219","article-title":"3D Printing and characterization of hydroxypropyl methylcellulose and methylcellulose for biodegradable support structures","volume":"34","author":"Polamaplly","year":"2019","journal-title":"Procedia Manuf."},{"key":"10.1016\/j.jconrel.2026.114863_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106501","article-title":"Mucoadhesive 3D printed vaginal ovules to treat endometriosis and fibrotic uterine diseases","volume":"188","author":"Teworte","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0275","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2024.11.021","article-title":"In vitro-in vivo correlation (IVIVC) development for long-acting injectable drug products based on poly(lactide-co-glycolide)","volume":"377","author":"Wang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114863_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bprint.2024.e00367","article-title":"Evolution, integration, and challenges of 3D printing in pharmaceutical applications: A comprehensive review","volume":"44","author":"Kumari","year":"2024","journal-title":"Bioprinting"},{"key":"10.1016\/j.jconrel.2026.114863_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bprint.2025.e00399","article-title":"Sterilizing bioinks: understanding the impact of techniques on 3D bioprinting materials","volume":"48","author":"Menon","year":"2025","journal-title":"Bioprinting"},{"key":"10.1016\/j.jconrel.2026.114863_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120142","article-title":"In-vitro drug release testing of parenteral formulations via an agarose gel envelope to closer mimic tissue firmness","volume":"594","author":"Ko\u017e\u00e1k","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0295","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1208\/s12249-016-0698-5","article-title":"Development of a convenient in vitro gel diffusion model for predicting the in vivo performance of subcutaneous parenteral formulations of large and small molecules","volume":"18","author":"Leung","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.114863_bb0300","article-title":"How bulk fluid renewal can affect in vitro drug release from PLGA implants: importance of the experimental set-up","volume":"4","author":"Bassand","year":"2022","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.jconrel.2026.114863_bb0305","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1111\/bcp.14735","article-title":"Effect of lipophilicity on drug distribution and elimination: influence of obesity","volume":"87","author":"Bruno","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2007.06.013","article-title":"An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots","volume":"122","author":"Deadman","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114863_bb0315","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1038\/s41598-025-93336-3","article-title":"Favorable pharmacokinetic and tolerability profiles make carprofen an attractive analgesic for subcutaneous injection and oral self-administration in rats","volume":"15","author":"Glasenapp","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114863_bb0320","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1021\/acs.molpharmaceut.2c00490","article-title":"Development of an in vitro system to emulate an in vivo subcutaneous environment: small molecule drug assessment","volume":"19","author":"Lou","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0325","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2022.01.028","article-title":"How agarose gels surrounding PLGA implants limit swelling and slow down drug release","volume":"343","author":"Bassand","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114863_bb0330","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","article-title":"In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114863_bb0335","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jconrel.2024.10.065","article-title":"Leveraging machine learning to streamline the development of liposomal drug delivery systems","volume":"376","author":"Eugster","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114863_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126362","article-title":"Machine learning-guided microfluidic optimization of clinically inspired liposomes for nanomedicine applications","volume":"686","author":"Buttitta","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114863_bb0345","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41598-020-79961-0","article-title":"Estimating mouse and rat use in American laboratories by extrapolation from animal welfare act-regulated species","volume":"11","author":"Carbone","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114863_bb0350","first-page":"1","article-title":"Evaluation of lidocaine and metabolite pharmacokinetics in hyaluronic acid injection","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114863_bb0355","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:INFL.0000041131.54496.51","article-title":"Central and peripheral tissue distribution of diclofenac after subcutaneous injection in the rat","volume":"8","author":"Grace","year":"2000","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jconrel.2026.114863_bb0360","doi-asserted-by":"crossref","first-page":"01394","DOI":"10.1128\/aac.01394-23","article-title":"Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models","volume":"68","author":"Jiao","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114863_bb0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.xphs.2018.06.003","article-title":"Investigation of drug delivery in rats via subcutaneous injection: case study of pharmacokinetic Modeling of suspension formulations","volume":"108","author":"Chiang","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2010.09.009","article-title":"Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats","volume":"31","author":"Prins","year":"2011","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0375","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/AAC.32.2.246","article-title":"Agents Chemother, pharmacokinetics of A40926 in rats after single intravenous and subcutaneous doses A40926 is a new glycopeptide antibiotic with unique activity against Neisseria gonorrhoeae and high and prolonged levels in mouse blood","volume":"32","author":"Bernareggi","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114863_bb0380","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0773.1991.tb01312.x","article-title":"Pharmacokinetics of clodronate after single intravenous, intramuscular and subcutaneous injections in rats","volume":"69","author":"Laur\u00e9n","year":"1991","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0385","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1007\/s00213-021-05981-x","article-title":"Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats","volume":"238","author":"Bergh","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jconrel.2026.114863_bb0390","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/AAC.01400-09","article-title":"Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro","volume":"54","author":"Sandberg","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114863_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1430726","article-title":"Subcutaneous and orally self-administered high-dose carprofen shows favorable pharmacokinetic and tolerability profiles in male and female C57BL\/6J mice","volume":"11","author":"Glasenapp","year":"2024","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13090231","article-title":"Pharmacokinetic comparison of three different administration routes for topotecan hydrochloride in rats","volume":"13","author":"Jeong","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2026.114863_bb0405","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.xphs.2018.06.009","article-title":"Preparation and evaluation of multifunctional autofluorescent magnetic nanoparticle\u2013based drug delivery systems against mammary cancer","volume":"107","author":"Li","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0410","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12917-021-02908-8","article-title":"Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling","volume":"17","author":"Liu","year":"2021","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.jconrel.2026.114863_bb0415","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/dta.3363","article-title":"Pharmacokinetics of freebase nicotine and nicotine salts following subcutaneous administration in male rats","volume":"15","author":"Han","year":"2023","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.jconrel.2026.114863_bb0420","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.xphs.2018.06.003","article-title":"Investigation of drug delivery in rats via subcutaneous injection: case study of pharmacokinetic Modeling of suspension formulations","volume":"108","author":"Chiang","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0425","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/npp.2016.213","article-title":"Pharmacokinetic profiles and pharmacodynamic effects for methylone and its metabolites in rats","volume":"42","author":"Elmore","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jconrel.2026.114863_bb0430","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02246454","article-title":"Wang, pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics","volume":"126","author":"Lau","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jconrel.2026.114863_bb0435","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00204-024-03887-z","article-title":"In vivo pharmacokinetic, pharmacodynamic and brain concentration comparison of fentanyl and Para-fluorofentanyl in rats","volume":"99","author":"Canfield","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ani10061050","article-title":"The pharmacokinetics of medetomidine administered subcutaneously during isoflurane anaesthesia in Sprague-dawley rats","volume":"10","author":"Kint","year":"2020","journal-title":"Animals"},{"key":"10.1016\/j.jconrel.2026.114863_bb0445","first-page":"78","article-title":"Pharmacokinetics of sustained release analgesics in mice","volume":"53","author":"Kendall","year":"2014","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0450","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0192-0561(92)90155-E","article-title":"Effects of subcutaneous versus intravenous administration of cyclosporin A on rat thymic histology and pharmacokinetics","volume":"14","author":"De Waal","year":"1992","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0455","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1124\/jpet.120.000191","article-title":"Physiologically based pharmacokinetic modeling involving nonlinear plasma and tissue binding: application to prednisolone and prednisone in rats","volume":"375","author":"Li","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2026.114863_bb0460","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vaa.2016.09.007","article-title":"Preliminary pharmacokinetics of tramadol hydrochloride after administration via different routes in male and female B6 mice","volume":"45","author":"Evangelista Vaz","year":"2018","journal-title":"Vet. Anaesth. Analg."},{"key":"10.1016\/j.jconrel.2026.114863_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116459","article-title":"Designer benzodiazepine rat pharmacokinetics: A comparison of alprazolam, flualprazolam and flubromazolam","volume":"465","author":"Canfield","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0470","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/AAC.38.1.79","article-title":"Effects of Polyaspartic acid on pharmacokinetics of tobramycin in two strains of rat","volume":"38","author":"Reinhard","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114863_bb0475","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/dmd.120.091017","article-title":"Physiologically based pharmacokinetics of dexamethasone in rats","volume":"48","author":"Song","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2026.114863_bb0480","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jchromb.2017.07.007","article-title":"Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method to quantify LY-354,740 in rat and marmoset plasma","volume":"1061\u20131062","author":"Gaudette","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0485","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jiac.2015.11.010","article-title":"Pharmacokinetics and brain penetration of carbapenems in mice","volume":"22","author":"Matsumoto","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jconrel.2026.114863_bb0490","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/0269881118780013","article-title":"The effect of route of administration on the enantioselective pharmacokinetics of ketamine and norketamine in rats","volume":"32","author":"Le Nedelec","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0495","first-page":"558","article-title":"Pharmacokinetics of single-bolus subcutaneous cefovecin in C57BL\/6 mice","volume":"56","author":"Sanders","year":"2017","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0500","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpain.2012.02.005","article-title":"(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats","volume":"13","author":"Lewis","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.jconrel.2026.114863_bb0505","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bdd.568","article-title":"Pharmacokinetics and metabolism of diltiazem in rats: comparing single vs repeated subcutaneous injections in vivo","volume":"28","author":"Yeung","year":"2007","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jconrel.2026.114863_bb0510","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-007-0926-5","article-title":"Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose","volume":"196","author":"P\u00e1len\u00ed\u010dek","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jconrel.2026.114863_bb0515","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.forsciint.2007.03.023","article-title":"Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses","volume":"170","author":"Ber\u00e1nkov\u00e1","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jconrel.2026.114863_bb0520","first-page":"534","article-title":"Pharmacokinetic profiles of nalbuphine after intraperitoneal and subcutaneous administration to C57BL\/6 mice","volume":"56","author":"Kick","year":"2017","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0525","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jvp.12297","article-title":"Subcutaneous meloxicam suspension pharmacokinetics in mice and dose considerations for postoperative analgesia","volume":"39","author":"Chen","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.114863_bb0530","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00008877-200203000-00001","article-title":"The effect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration-effect relations","volume":"13","author":"Lau","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0535","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1472-8206.2009.00803.x","article-title":"Effects of induced hyperthermia on pharmacokinetics of ropivacaine in rats","volume":"24","author":"Guilhaumou","year":"2010","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0540","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.jconrel.2026.114863_bb0545","article-title":"Using machine learning to predict the antibacterial activity of ruthenium complexes**","volume":"63","author":"Orsi","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114863_bb0550","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1021\/acs.chemrev.4c00893","article-title":"Studying noncovalent interactions in molecular systems with machine learning","volume":"125","author":"Tretiakov","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.114863_bb0555","author":"Lundberg"},{"key":"10.1016\/j.jconrel.2026.114863_bb0560","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s42256-020-00236-4","article-title":"Drug discovery with explainable artificial intelligence","volume":"2","author":"Jim\u00e9nez-Luna","year":"2020","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.jconrel.2026.114863_bb0565","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.jconrel.2026.114863_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.eswa.2023.120470","article-title":"Automatic feature engineering for learning compact decision trees","volume":"229","author":"Roshanski","year":"2023","journal-title":"Expert Syst. Appl."},{"key":"10.1016\/j.jconrel.2026.114863_bb0575","doi-asserted-by":"crossref","first-page":"23566","DOI":"10.1021\/acsomega.3c01218","article-title":"Molecular representations in machine-learning-based prediction of PK parameters for insulin Analogs","volume":"8","author":"Einarson","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2026.114863_bb0580","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1021\/jm900403j","article-title":"Physicochemical determinants of human renal clearance","volume":"52","author":"Varma","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114863_bb0585","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13318-021-00748-3","article-title":"Predicting the drug clearance pathway with structural descriptors","volume":"47","author":"Kaboudi","year":"2022","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2026.114863_bb0590","article-title":"Design principles for balancing lipophilicity and permeability in beyond rule of 5 space","volume":"19","author":"M\u00f6bitz","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2026.114863_bb0595","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jcph.1842","article-title":"Modeling complex pharmacokinetics of long-acting injectable products using convolution-based models with nonparametric input functions","volume":"61","author":"Gomeni","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114863_bb0600","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ccr3.2772","article-title":"Use of intravenous lipid therapy in a cat with carprofen overdose","volume":"8","author":"Chumbler","year":"2020","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.jconrel.2026.114863_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2024.101875","article-title":"Liposomes: bridging the gap from lab to pharmaceuticals","volume":"75","author":"Eugster","year":"2025","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.114863_bb0610","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/pharmaceutics17050626","article-title":"Unveiling the future: opportunities in long-acting injectable drug development for veterinary care","volume":"17","author":"Koppisetti","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114863_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125452","article-title":"Best practice for the size analysis of nanomedicines \u2013 an iron sucrose case study","volume":"674","author":"Coones","year":"2025","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:03:59Z","timestamp":1779757439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":123,"alternative-id":["S0168365926002658"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114863","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward animal-free approaches in subcutaneous drug delivery: A pain management case study","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114863"}}